Pharmaceutical composition for treating lacunar infarction and preparation method thereof

Abstract

The invention discloses a pharmaceutical composition for treating lacunar infarction and a preparation method thereof. The pharmaceutical composition is prepared from herb of heterophyllous eupatorium, herb of bulbophyllum odoratissimum (Swartz) Lindl., rhizoma curcumae, radix cudramiae, roots of sarcococca ruscifolia stapf, lilium brownii, seeds of brassica campestris L., licorice roots, roots, leaves and fruit of zanthoxylum avicennae (Lam.)DC., India mustard seeds, musk, cortex eucommiae, retinervus citri reticulatae, fructus mume, roots of fissistigma oldhami (Hemsl.) Merr., leaves or root bark of apanea neriifolia (Sieb.Et Zucc.)Mez., retinervus luffae fructus, roots, leaves and flowers of viburnum cylindricum Buch.-Ham. ex D. Don, radix notoginseng, herba taraxaci, herb of polygonum sieboldii Meisn., membranaceous beautyleaf roots, herb or roots of abutilon indicum (L.)G. Don, rhizomes and tender leaves of smilax glauco-china Warb., flos carthami, herb of lygodium japonicum(Thunb.)Sw, stems and roots of dalbergia hancei Benth., radix gentianae macrophyllae, ovate leaf holly bark and roots and herb of cyananthus argernteus Marg.. The pharmaceutical composition has the effects of promoting blood circulation to remove blood stasis, inducing resuscitation with herbal aromatics, dredging the channels, relieving hydrocephalus and improving microcirculation and has the advantages of being capable of rapidly achieving the effects, high in effective rate, exact in treatment effect, short in treatment course, capable of enhancing the effects, reducing toxicity and achieving multi-target treatment, low in cost and the like.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a pharmaceutical composition for treating lacunar infarction and a preparation method thereof. Background technique [0002] Lacunar infarction is a relatively common type of cerebral infarction, accounting for about 20% of cerebral infarction. Completely different from atherosclerotic cerebral thrombosis, lacunar infarction mainly occurs in the deep penetrating branches of the anterior, middle, and posterior cerebral arteries and vertebral-basilar arteries and their branches, mainly caused by hypertension and its accompanying Caused by arteriolar hyaline degeneration or arterial embolism, the symptoms are relatively simple. It mostly occurs in the middle-aged and elderly people aged 40-60 and above, more men than women, the risk of lacunar infarction increases 8 times in hypertensive patients, and increases 5.6 times in smokers. Diabetic patients increase...

AI Technical Summary

Problems solved by technology

2. Simple dysarthria type: All have mild language impairment, manifested as ambiguous speech, inaccurate pronunciation and intonation, but no phonemic errors, and can be completely understood. Some patients have poor sense of sound and slow speech

6. Vascular dilation: It is generally believed that the effect of vasodilators is uncertain. For severe patients with increased intracranial pressure, sometimes it can aggravate the condition, so it is not recommended to use it in the early stage

While treating cerebral infarction, western medicine has certain side effects on the liver, kidney, digestive tract and nervous system; moreover, many western medicines, including aspirin, are drug-resistant, because western medicine cannot deal with multiple links for the complicated etiology of cerebral infarction. Treatment, its pharmacological effect is reflected in a chemical molecular formula, which means that a molecular formula can only prevent and treat one link, and the long-term effect is poor

Therefore, western medicine treatment of cerebral infarction is not suitable for long-term use in the recovery period and sequelae period; moreover, western medicine treatment is not conducive to the treatment, and it often has dependence and side effects.